GSK's Cervarix may have been the first HPV shot approved in mainland China, but Merck's Gardasil now has an opening to gain the lead.
Alexion’s C-suite makeover continues as four top execs prepare to depart, and new CEO Ludwig Hantson makes his first key hire.
AstraZeneca finally has cardiovascular outcomes data for one of its top diabetes contenders. But the new results don’t measure up to rivals' studies.
AstraZeneca's respiratory candidate benralizumab can help some severe asthma patients cut down on the steroid pills they use to stave off attacks.
Novo Nordisk is revving up for a push into Latin America with obesity drug Saxenda, hoping to put sales into a higher gear.
California lawmakers are weighing a bill that would cut off most drugmaker payments to physicians, including speaking fees for that staple of pharma marketing…
Hospitals are dealing with a shortage of sodium bicarbonate, a drug whose active ingredient is essentially the same one that cooks know as baking soda.…
Nevada’s Senate has passed a tough new bill that would publicly spotlight insulin makers' price hikes and profits.
Soap operas often include medical mysteries and miracles, but some doctors are concerned about Incyte's connection to General Hospital's latest drama.
Amgen says it’ll be a while before its bone drug romosozumab can fight Radius' Tymlos for market share—if it can get it there at all.